Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman. As the founder of Sun Pharmaceuticals, he is one of the country's richest people. The Government of India awarded him the civilian honor of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.

  2. Dilip Shanghvi, 2015. Dilip Shanghvi (* 1. Oktober 1955 in Amreli, Gujarat) ist ein indischer Unternehmer. Leben. Shangvi studierte Wirtschaftswissenschaften an der University of Calcutta und gründete 1982 das indische Unternehmen Sun Pharmaceutical, dessen Leitung er gegenwärtig innehat.

  3. www.forbes.com › profile › dilip-shanghviDilip Shanghvi - Forbes

    Vor 3 Tagen · Learn about Dilip Shanghvi, the self-made billionaire who founded Sun Pharmaceutical Industries and acquired Ranbaxy Laboratories. See his net worth, wealth history, personal stats, photos, quotes and articles.

  4. Dilip Shanghvi is the Founder and Chairman and Managing Director of Sun Pharmaceutical Industries Limited. He is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in R&D of new innovative drugs and delivery technologies.

  5. 11. Okt. 2023 · Dilip Shanghvi is the founder and chairman of Sun Pharmaceutical Industries, India's most valuable listed pharma outfit. He started the company with a $200 loan from his father and grew it through acquisitions, including Ranbaxy Laboratories in 2014.

  6. Vor 3 Tagen · Dilip Shanghvi is the founder of Sun Pharmaceutical Industries, a generic drugmaker with revenue of $5.4 billion in 2023. He is the richest person in India with a net worth of $25 billion as of May 2024, according to Bloomberg.

  7. 8. Mai 2024 · Dilip Shanghvi, Indian business executive who was the founder (1983) of Sun Pharmaceutical Industries Ltd., which became the largest pharmaceutical company in India and one of the largest generic-drug producers in the world. Learn more about Shanghvi’s life and career.